Bioxcel Therapeutics Inc (BTAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 127,545 | 165,521 | 193,725 | 232,314 | 233,452 |
| Receivables | 431 | 283 | 248 | N/A | N/A |
| Inventories | 1,925 | 1,952 | 1,985 | 1,408 | 1,395 |
| Other current assets | 4,636 | 5,006 | 3,843 | 2,430 | 1,693 |
| TOTAL | $138,235 | $177,268 | $202,868 | $241,661 | $244,924 |
| Non-Current Assets | |||||
| PPE Net | 941 | 1,004 | 1,084 | 1,187 | 1,272 |
| Other Non-Current Assets | 921 | 1,831 | 1,901 | 1,970 | 2,039 |
| TOTAL | $1,862 | $2,835 | $2,985 | $3,157 | $3,311 |
| Total Assets | $140,097 | $180,103 | $205,853 | $244,818 | $248,235 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,057 | 8,122 | 10,650 | 6,141 | 6,317 |
| Accrued Expenses | 19,128 | 17,065 | 18,669 | 13,949 | 13,372 |
| Other current liabilities | 453 | 484 | 404 | 392 | 306 |
| TOTAL | $34,744 | $28,759 | $32,898 | $23,378 | $19,995 |
| Non-Current Liabilities | |||||
| Long Term Debt | 96,846 | 95,062 | 93,051 | 91,695 | 61,075 |
| Other Non-Current Liabilities | 2,643 | 3,277 | 3,129 | 2,759 | 2,903 |
| TOTAL | $99,489 | $98,339 | $96,180 | $94,454 | $63,978 |
| Total Liabilities | $134,233 | $127,098 | $129,078 | $117,832 | $83,973 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,829 | 1,822 | 1,813 | 1,751 | 1,751 |
| Common Shares | 29 | 29 | 28 | 28 | 28 |
| Retained earnings | -517,856 | -464,341 | -411,545 | -356,737 | -314,930 |
| TOTAL | $5,864 | $53,005 | $76,775 | $126,986 | $164,262 |
| Total Liabilities And Equity | $140,097 | $180,103 | $205,853 | $244,818 | $248,235 |